Effectiveness and safety of probiotics in treating knee osteoarthritis: an updated systematic review and meta-analysis of randomized controlled trials - Report - MDSpire

Effectiveness and safety of probiotics in treating knee osteoarthritis: an updated systematic review and meta-analysis of randomized controlled trials

  • By

  • Keye Chen

  • Yan Sun

  • Longkang Cui

  • Yuchen Zhu

  • Bingbing Zhang

  • Lianguo Wu

  • June 16, 2026

  • 0 min

Share

Clinical Report: Efficacy and Safety of Probiotics for Knee Osteoarthritis

Overview

This systematic review and meta-analysis evaluate the efficacy and safety of probiotics in treating knee osteoarthritis (KOA). Probiotics, particularly Saccharomyces boulardii and LatiLactobacillus sakei LB-P12, show potential benefits for KOA symptoms, although evidence is limited by small sample sizes and methodological concerns.

Background

Knee osteoarthritis is a common degenerative joint disease that significantly impacts mobility and quality of life, especially in older adults. Current treatment options often have limitations, leading to interest in alternative therapies such as probiotics, which may address gut microbiota dysbiosis linked to KOA. Understanding the role of probiotics could provide new avenues for managing this prevalent condition.

Data Highlights

No significant adverse events were reported for probiotics compared to placebo, indicating a favorable safety profile.

Key Findings

  • Probiotics may improve KOA symptoms, particularly pain and function, as measured by VAS and WOMAC scores.
  • Saccharomyces boulardii and LatiLactobacillus sakei LB-P12 showed strain-specific efficacy.
  • No serious safety issues were identified in the studies reviewed.
  • Evidence is limited by small sample sizes and methodological inconsistencies across trials.
  • Further research is needed to establish definitive clinical guidelines for probiotic use in KOA.

Clinical Implications

Clinicians should consider the potential benefits of probiotics for KOA, particularly in patients seeking alternatives to traditional therapies. However, due to the limited evidence base, probiotics should not yet be considered a first-line treatment.

Conclusion

Probiotics present a promising adjunctive therapy for knee osteoarthritis, but further rigorous studies are essential to confirm their efficacy and safety in clinical practice.

Related Resources & Content

  1. Clinical Rheumatology, 2022 -- Assessment of colchicine's effectiveness and safety in managing osteoarthritis: a systematic review and meta-analysis of clinical trials
  2. Effectiveness and Economic Impact of Physiotherapy After Total Knee Arthroplasty, 2021 -- A Comprehensive Review and Meta-Analysis
  3. Frontiers in Medicine, 2026 -- Efficacy and safety of different curcumin formulations in osteoarthritis: an umbrella review of systematic reviews
  4. Frontiers in Surgery, 2026 -- Meta-analysis of efficacy of probiotics in reducing postoperative infections and improving outcomes in gastrointestinal surgery
  5. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee - PubMed
  6. Frontiers | Effectiveness and Safety of Probiotics in Treating Knee Osteoarthritis: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials, 2026
  7. The gut–joint axis in osteoarthritis | Nature Reviews Rheumatology, 2026
  8. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee - PubMed
  9. Frontiers | Effectiveness and Safety of Probiotics in Treating Knee Osteoarthritis: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
  10. The gut–joint axis in osteoarthritis | Nature Reviews Rheumatology

Original Source(s)

Related Content